Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and …
Over the last 12 months, insiders at Seer, Inc. have bought $0 and sold $188,865 worth of Seer, Inc. stock.
On average, over the past 5 years, insiders at Seer, Inc. have bought $34.35M and sold $70.26M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 40,000 shares for transaction amount of $97,968 was made by Farokhzad Omid (CEO, President and Chair) on 2023‑08‑23.
2024-06-14 | Sale | director | 12,109 0.0183% | $1.78 | $21,512 | -0.56% | ||
2024-03-07 | Sale | CEO AND CHAIR | 52,857 0.0808% | $2.03 | $107,421 | -12.26% | ||
2024-02-22 | Sale | PRESIDENT & CFO | 12,684 0.0213% | $1.58 | $20,024 | +15.92% | ||
2024-02-22 | Sale | CHIEF LEGAL OFFICER | 12,684 0.0213% | $1.58 | $20,024 | +15.92% | ||
2024-02-05 | Sale | President and CFO | 3,608 0.0053% | $1.67 | $6,015 | +8.38% | ||
2023-12-04 | Sale | Chief Legal Officer | 8,182 0.0136% | $1.70 | $13,869 | +5.57% | ||
2023-08-23 | CEO, President and Chair | 40,000 0.0641% | $2.45 | $97,968 | -24.27% | |||
2023-05-18 | Sale | Chief Commercial Officer | 1,468 0.0023% | $3.56 | $5,224 | -46.68% | ||
2023-02-21 | Sale | CEO, President and Chair | 13,840 0.0229% | $4.13 | $57,210 | -33.76% | ||
2023-02-21 | Sale | Chief Financial Officer | 5,951 0.0098% | $4.13 | $24,606 | -33.76% | ||
2023-02-21 | Sale | General Counsel and Secretary | 5,951 0.0098% | $4.13 | $24,603 | -33.76% | ||
2023-02-07 | Sale | CEO, President and Chair | 8,379 0.0129% | $4.67 | $39,128 | -38.28% | ||
2023-02-07 | Sale | Chief Financial Officer | 3,124 0.0056% | $5.40 | $16,861 | -38.28% | ||
2023-01-17 | Sale | CEO, President and Chair | 4,800 0.0071% | $5.12 | $24,573 | -34.47% | ||
2023-01-17 | Sale | Chief Financial Officer | 2,602 0.0039% | $5.12 | $13,320 | -34.47% | ||
2022-12-08 | Sale | Chief Financial Officer | 18,884 0.0303% | $6.57 | $124,070 | -40.94% | ||
2022-06-08 | Sale | General Counsel and Secretary | 8,185 0.0128% | $8.91 | $72,923 | -31.84% | ||
2022-05-27 | Sale | President & COO | 4,441 0.0065% | $8.06 | $35,794 | -27.01% | ||
2022-04-20 | Sale | President & COO | 52,042 0.0833% | $10.18 | $529,933 | -29.12% | ||
2022-02-02 | Sale | Chief Financial Officer | 2,944 0.0046% | $17.40 | $51,226 | -52.10% |
Farokhzad Omid | CEO AND CHAIR | 1436285 2.3381% | $2.04 | 1 | 7 | |
Invus Public Equities, L.P. | 10 percent owner | 5588366 9.0973% | $2.04 | 1 | 1 | <0.0001% |
aMoon Growth Fund Limited Partnership | 10 percent owner | 810961 1.3202% | $2.04 | 2 | 1 | <0.0001% |
MCGUIRE TERRANCE | director | 78947 0.1285% | $2.04 | 1 | 0 | <0.0001% |
AINSLIE LEE S III | 10 percent owner | 22620 0.0368% | $2.04 | 1 | 0 | <0.0001% |
BlackRock | $10.73M | 8.7 | 5.65M | -2.46% | -$270,577.13 | <0.0001 | |
Softbank Group Corp | $9.76M | 7.91 | 5.14M | 0% | +$0 | 0.05 | |
Artal Group S A | $9.03M | 7.32 | 4.75M | 0% | +$0 | 0.04 | |
The Vanguard Group | $5.01M | 4.06 | 2.64M | +0.99% | +$49,293.60 | <0.0001 | |
Capital World Investors | $3.91M | 3.17 | 2.06M | 0% | +$0 | <0.01 |